Kreitman, R. J., & Pastan, I. (2019). Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia. Oncologist.
Stile di citazione ChicagoKreitman, Robert J., e Ira Pastan. "Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia." Oncologist 2019.
Citazione MLAKreitman, Robert J., e Ira Pastan. "Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia." Oncologist 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.